Member Info for Rahulrajas

Oh GREAT. As far as I know there’s only one nebulised CIVID19 trial/treatment and that’s SNG001

https://www.londonstockexchange.com/exchange/prices-and-markets/stocks/exchange-insight/trade-data.html?page=4&pageOffBook=0&fourWayKey=GB00B0381Z20GBGBXASX1&formName=frmRow&upToRow=-1

"Just to keep this clear - that is an injected interferon product. This is not the same as SNG001, our inhaled product."

Oh, ok. Didn't realise that.

Critical anonymized information for the trial will only be collected at the randomization stage and when the patient is discharged or dies: which study drugs were given (and for how many days); whether ventilation or intensive care was received (and, if so, when it began), date of discharge, or date and cause of death while still in hospital.

Interim trial analyses are monitored by a Global Data and Safety Monitoring Committee, which is an independent group of experts.

https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments
Adults (age =18 years) recently hospitalised, or already in hospital, with confirmed COVID-19 and, in the view of the responsible doctor, no contra-indication to any of the study treatments will be randomly allocated between

? Local standard of care,

OR local standard of care plus one of

? Remdesivir

? Chloroquine or Hydroxychloroquine

? Lopinavir with Ritonavir

? Lopinavir with Ritonavir plus Interferon beta-1a.

I don’t think so.